AMENDMENT NO. 2 TO LICENSE AGREEMENTLicense Agreement • March 15th, 2023 • HOOKIPA Pharma Inc. • Pharmaceutical preparations
This amendment (the “Amendment No. 2”) is a modification of the License Agreement by and between University of Basel, having its principal place of business at Petersgraben 35, CH-4001 Basel, Switzerland (“UNIVERSITY”), and Hookipa Biotech GmbH, having its principal place of business at Helmut-Qualtinger-Gasse 2, 1030 Vienna, Austria (“LICENSEE”), effective as of October 15, 2020 (the "Agreement"), as first amended by and among the Parties by entering into a first amendment, effective July 11, 2022.
AMENDMENT NO. 1 TO LICENSE AGREEMENTLicense Agreement • March 15th, 2023 • HOOKIPA Pharma Inc. • Pharmaceutical preparations
This Amendment (“Amendment”) is a modification of the License Agreement by and between University of Basel, having its principal offices located at Petersgraben 35, 4001 Basel, Switzerland (“UNIBAS”) and Hookipa Biotech GmbH, having its principal offices located at Helmut-Qualtinger-Gasse 2, 1030 Vienna, Austria (“Hookipa”), made effective on October 15, 2020 ("Agreement").
